Dr. Honora Englander honored at the WE ARE CODA Advocacy Awards luncheon

Dr. Honora Englander, MD, FACP, Director/PI, Improving Addiction Care Team (Project IMPACT) at Oregon Health & Science University, was honored at this year’s event on April 4.

Check out the terrific coverage in Portland’s Society Page!

Check out the We Are CODA 2017 video!

To learn more about the great work going on at OHSU in our field, check out this fantastic video.

And, finally, for more photos of our event, check out CODA’s Facebook page.

Many thanks to our generous 2017 sponsors, The Standard, Morel Ink and OHSU!

(From left, CODA Executive Director Tim Hartnett, Dr. Englander and Mayor Ted Wheeler, who served as MC of the event. //Andie Petkus Photography)

Put your heart into it!

All too often, substance use disorders can be viewed as health challenges that exist separately from other conditions. SAMHSA (the federal Substance Use and Mental Health Services Administration) has been a partner in the Million Hearts Initiative with the Department of Health and Human Services (HHS). This initiative has focused […] Read more »

The value of methadone

Methadone remains one of the most effective medicines for treating opioid use disorders. Check out this thoughtful article in The Fix by Jessica Gregg, MD. Read more »

Looking for Co-dependents Anonymous?

Co-dependents Anonymous has a domain name very close to that of our agency. We are codainc.org and they are coda.org — coda without the “inc”.   If you’re looking for the Co-Dependents Anonymous site, which has lots of useful info, you will find it at coda.org Read more »

Utah’s opioid crisis

A fascinating article in a newspaper based in the United Kingdom looks at the opioid use disorders problem in Utah, focusing on people in the state who, for religious reasons, avoid all recreational drugs but get dependent on prescription medications. Here is a paragraph from the story in The Guardian, […] Read more »

Fentanyl deaths on the rise

A New York Times article cites a surge in deaths from fentanyl. The prescription drug is intended for use as pain medication for cancer patients and as an anesthetic for surgery. “Nearly half of all unintentional drug overdose deaths in [New York City] since July have involved fentanyl,” according to […] Read more »

It’s Toy Drive time!

CODA was invited by Wells Fargo and KGW-TV to join local area non-profits in a celebration and toy collection event for #TheGreatToyDrive! Check it out on our Facebook page! Read more »

Check out our FB: Surgeon General on opioids

Check out CODA’s Facebook page and read about the Surgeon General’s latest remarks on America’s addiction crisis. Our FB page is updated frequently with news about recovery, substance use disorders and healthcare, as well as the latest on CODA events. (Scroll down to catch up on the posts you’ve missed!) Read more »

Check out CODA Outpatient!

CODA’s latest video provides a great look into our Outpatient programs, located in Multnomah, Washington and Clackamas counties. (CODA employees participated in the making of this video, playing the parts of patients.) Read more »

Deadly synthetic opioid taking lives

A deadly opioid is causing a record number of overdose deaths in the Midwest. The drug is a synthetic opioid (meaning, it is made in a lab, not from poppies) called carfentanil, and experts say it is “100 times more potent than fentanyl, the prescription painkiller that led to the […] Read more »